Relief of Lumbar Spinal Stenosis Symptoms
Comparison of Pulsed Radiofrequency Stimulation Versus Dexamethasone Applied to the Caudal Epidural Space for the Relief of Lumbar Spinal Stenosis Symptoms
1 other identifier
interventional
50
1 country
2
Brief Summary
The aim of this study was to compare the efficacy of caudal epidural steroid injection and caudal epidural pulsed radiofrequency stimulation in the relief of symptoms of lumbar spinal stenosis. This evaluation used the numerical rating scale (NRS) to assess pain relief and the Medication Quantification Scale III (MQS III) to assess the effectiveness of the interventions on medication consumption. The rates of adverse events related to the interventions were also compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2024
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2024
CompletedFirst Submitted
Initial submission to the registry
April 27, 2024
CompletedFirst Posted
Study publicly available on registry
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2024
CompletedJuly 22, 2024
July 1, 2024
5 months
April 27, 2024
July 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Numerical rating scale (NRS)
NRS is a scale that can be used measuring pain. Scores range from 0 (no pain) to 10 (the worst pain)
Change from baseline to 1st,2nd and 3th month after treatment
Secondary Outcomes (1)
The Medication Quantification Scale III (MQS III)
Change from baseline to 1st,2nd and 3th month after treatment
Study Arms (2)
pulsed radiofrequency group
ACTIVE COMPARATORCaudal epidural pulsed radiofrequency for lumbar spinal stenosis
steroid enjection grroup
ACTIVE COMPARATORCaudal epidural steroid enjection for lumbar spinal stenosis
Interventions
The patient lied in prone position. After cutaneous and subcutaneous anesthesia with 3 ml of 2% lidocaine, a 22- gauge 150-mm RF cannula with 20 mm active tip was advanced through the sacrococcygeal ligament into the caudal epidural space under floroscopic guidence. A few milliliters contrast was injected to observe the expansion of the epidural space. After correct needle placement was confirmed, an electrode was connected to the cannula, and stimulation was conducted with impedance measured between 250 and 350 Ohms A different sensation or feeling such as fullness, impression, tingling, pulling or plethora at the rectal and/or coccygeal region was observed by the patients when 50 Hz was applied with 0,4 to 0,7 V sensory stimulation. No leg muscle contraction was observed with 2 Hz motor stimulation at 2 V. PRF was performed for 600 s at 5 Hz using a 5-ms pulse width at 55 V, avoiding electrode tip temperatures above 42 C.
The patient lied in prone position and aseptic techniques were adopted. After cutaneous and subcutaneous anesthesia with 3 ml of 2% lidocaine, a spinal needle was advanced through the sacrococcygeal ligament into the caudal epidural space under fluoroscopic guidance. The needle tip was confirmed by negative aspiration for blood or cerebrospinal fluid, then a few milliliters of contrast was injected to observe the expansion of the epidural space. After correct needle placement was confirmed, a total of 10 ml mixture of saline and 8 mg dexametzone was administered into the epidural space.
Eligibility Criteria
You may qualify if:
- Among the patients with lumbar spinal stenosis findings and narrowing of the spinal canal detected by examination and imaging methods, those whose back and leg pain persists for at least 3 months
You may not qualify if:
- Previous lumbar surgery, pregnancy, history of ongoing malignant disease, autoimmune diseases, active infection of the injection site, hematologic disorders, antiplatelet drug use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Damla Yürük
Ankara, Türkiye, 5319932, Turkey (Türkiye)
Ankara Etlik City Hospital
Ankara, Yenimahalle, 5319932, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ömer Taylan T Akkaya, Prof
Department of Algology, Ankara Etlik City Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Supervisor Investigator
Study Record Dates
First Submitted
April 27, 2024
First Posted
May 1, 2024
Study Start
February 15, 2024
Primary Completion
July 19, 2024
Study Completion
July 20, 2024
Last Updated
July 22, 2024
Record last verified: 2024-07